Agios Pharmaceuticals Statistics, Revenue Totals and Facts (2021)

Here are a few of the most interesting Agios Pharmaceuticals statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.

Agios Pharmaceuticals Facts

  • Website: Official Website
  • Year Founded: 2008
  • Headquarters: Cambridge, MA
  • Founder(s): Lewis Cantley, Tak Mak and Craig Thompson
  • Current Chief Executive: Jackie Fouse

What is Agios Pharmaceuticals?

Developing breakthrough medicines for patients with genetically defined diseases is incredibly important, and so challenging. It takes great science. But it also takes an environment where people care – about the work, about each other, and about patients. At our core, we’re a biopharmaceutical company passionately committed to applying our leadership in the field of cellular metabolism to transform the lives of patients. We’re a science-driven, patient-focused organization developing transformative therapies for genetically defined diseases. Patients are counting on us, and we’re driven by a sense of urgency to help. We challenge ourselves to think big and welcome different perspectives and backgrounds. Our research engine continues to yield new insights and potential therapeutic approaches, growing our differentiated portfolio of preclinical and clinical programs. Through it all, we are propelled by our connections with one another and our shared goal of doing something extraordinary on behalf of those in need. Together, we can achieve the Other Side of Possible. (source)

Agios Pharmaceuticals Employee Count

Number of Agios Pharmaceuticals employees:

550 employees

Last updated 3/22/20

Agios Pharmaceuticals Statistics

Agios Pharmaceuticals annual revenue:

Agios Pharmaceuticals annual net income:

Please note that some of these numbers are easier to find than others. A few of these Agios Pharmaceuticals stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.